Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Histopathology. 2020 Sep 14;78(2):252–264. doi: 10.1111/his.14211

Figure 3.

Figure 3.

Risk of disease recurrence for cases with low tumour budding (TB) compared to cases with intermediate, and high TB (left). Cumulative probability of disease recurrence using a combination of intraepithelial tumour infiltrating lymphocytes (iTILs) and TB (right) (hazard ratios and 95% confidence intervals presented in Supporting information, Table S1).